Joseph Polli

About Joseph Polli

Accountable for the global scientific publication strategy for ViiV’s cabotegravir + rilpivirine long-acting program (Cabenuva) for HIV treatment. Responsible for tracking publications, training speakers, managing dozens of authors and preparing materials for external presentations/internal training. • ViiV Healthcare data disclosure compliance and governance liaison to GSK managing timing of disclosure as per regulatory requirements and corporate policy. • Over thirty years of research leadership and experience with 25 years in the Pharmaceutical Industry supporting Drug Metabolism and Pharmacokinetics (DMPK) in drug development, with an emphasis on mechanisms of drug disposition (transport and metabolism), in particular for central nervous system penetration, gastrointestinal drug absorption, liver disposition and drug-drug interactions.• Skilled in organizational, managerial and technical areas with a proven track record of cross-departmental leadership, change management, teamwork, productivity, interpersonal and staff development skills.• Over 20 years of supervisory experience directing and guiding PhD, MS and BS level scientists in the design, execution and publication of in vitro and in vivo DMPK studies supporting the metabolic, anti-viral, dermal and other therapeutic area drug candidates. • Successful record of establishing independent research programs to meet corporate goals, leading project teams, and professional development of permanent staff, postdoctoral fellows and graduate students. I have led/co-led numerous international multidisciplinary teams of scientists evaluating and implemented new technologies pertinent for drug disposition in a global organization, as well as teams focused on increased productivity and predictivity of in vitro ADME studies.• Strong external leadership in professional societies: AAPS Board of Directors as President (2020; term 20••••22) and Member-at-Large (20••••18), 2015 AAPS Annual Meeting Planning Committee Chair (4-year term), 2013 PPDM Section Chair (4-year term) and AAPS PPDM Secretary and Treasurer (2 terms, 2 years each), Graduate Faculty and lecturer at University of North Carolina, External Opponent for Doctoral defenses for Uppsala University, participation in PhRMA/IQ and ITC Consortium working groups on drug transporters and metabolism, committee member and symposium organizer for multiple local scientific discussion groups (e.g, RTP, CACO).Specialties: drug Transporters and metabolism, pharmacogenetics, drug interactions

Experience

1. Senior Director, Project Specialist, Nonclinical Safety and Dmpk

   Viiv Healthcare

   Nov 2022 — Present · Durham, NC, US

Education

• Penn State University

  Bachelor's degree, Cell/Cellular and Molecular Biology

  1982 — 1986

• Pennsylvania State University College of Medicine

  PhD, Pharmacology

  1986 — 1990

Skills

• Drug Interactions
• Toxicology
• Drug Discovery
• Biotechnology
• Pharmaceutical Industry
• Lecturing
• Pharmacokinetics
• Pharmacodynamics
• In Vitro
• Drug Metabolism
• Cell Biology
• Dmpk
• Immunology
• Drug Development
• Bioanalysis
• Biochemistry
• Pharmacology
• Regulatory Submissions
• In Vivo
• Clinical Development
• Pharmacogenetics